Group One Trading LLC Boosts Stake in ARK Genomic Revolution ETF $ARKG

Group One Trading LLC lifted its position in ARK Genomic Revolution ETF (BATS:ARKG) by 168.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 45,861 shares of the company’s stock after purchasing an additional 28,765 shares during the quarter. Group One Trading LLC’s holdings in ARK Genomic Revolution ETF were worth $1,212,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its position in ARK Genomic Revolution ETF by 30.6% during the fourth quarter. JPMorgan Chase & Co. now owns 5,149,454 shares of the company’s stock worth $149,180,000 after buying an additional 1,205,541 shares during the period. Morgan Stanley lifted its stake in ARK Genomic Revolution ETF by 42.2% in the fourth quarter. Morgan Stanley now owns 4,025,965 shares of the company’s stock valued at $116,632,000 after buying an additional 1,193,795 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of ARK Genomic Revolution ETF by 49.7% in the fourth quarter. BNP Paribas Financial Markets now owns 3,514,980 shares of the company’s stock valued at $101,829,000 after acquiring an additional 1,167,558 shares during the period. Wells Fargo & Company MN boosted its holdings in shares of ARK Genomic Revolution ETF by 29.1% in the fourth quarter. Wells Fargo & Company MN now owns 1,287,390 shares of the company’s stock valued at $37,296,000 after acquiring an additional 290,301 shares during the period. Finally, Royal Bank of Canada grew its position in shares of ARK Genomic Revolution ETF by 185.0% during the fourth quarter. Royal Bank of Canada now owns 445,592 shares of the company’s stock worth $12,910,000 after acquiring an additional 289,237 shares during the last quarter.

ARK Genomic Revolution ETF Stock Performance

Shares of ARKG opened at $38.85 on Thursday. The company’s 50 day simple moving average is $36.44 and its 200-day simple moving average is $31.80. ARK Genomic Revolution ETF has a 12-month low of $22.73 and a 12-month high of $44.47.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.